1 hten or as the pre-decerebration anaesthesia wore off.

2 he intubating dose of a muscle relaxant have worn off.

3  baseline levels after the effects of PL had worn off.

4 me without troublesome dyskinesia and reduce wearing off.

5 ong aversive effects after rewarding effects wear off, accompanied by increased firing in the lateral

6 s protective effect of reduced autophagy had worn off after 7 weeks on a high fat diet.

7 mptoms and restlessness, along with nonmotor wearing off and akathisia.

8  "off" time (time when medication effect has worn off and parkinsonian features, including bradykines

9 emor, worsening symptoms when the medication wears off, and dyskinesias.

10 he parafoveal locations and such modulations wore off as visual stimuli appeared closer to the fovea

11                     The first development of wearing off, dyskinesias, or on-off motor fluctuations w

12 on disease (PD), its use is often limited by wearing off effect and dyskinesias.

13 riteria, were on dopaminergic treatment with wearing-off effects, and were at Hoehn and Yahr stage 2.

14 a-treated PD subjects experiencing prominent wearing-off motor fluctuations.

15 treated eyes was increased IOP attributed to wearing off of efficacy.

16 functional impairment when a medication dose wears off ("off periods"), medication-resistant tremor,

17                                     Ten with wearing-off phenomenon were assessed twice, off and on c

18 ion, and taking dopaminergic medication with wearing-off phenomenon were included.

19 tion appears rapidly after use commences and wears off rapidly after use ceases.

20 t peak dose and typically alternate with the wearing-off state.

21  in motor fluctuations, particularly of the "wearing-off" type, with about 1.0-1.7 h more on-time and

22  implying that suppression may accumulate or wear off with time.